Named in 1 fund letter, by Lux Capital.
| Lux Capital | Josh Wolfe | 1 | 2026–2026 |
| Lux Q3 2026 Report | Josh Wolfe argues that new instruments expose the anomalies that break paradigms, reports that 24 of the roughly 25 Lux companies that raised in Q3 did so at a median 1.7x step-up, and names six market anomalies, from a 5.36% 10-year yield to debt-funded hyperscaler capex. | Lux Capital | Josh Wolfe | Q3 2026 |